Federal authorities are investigating after some COVID-19 vaccine recipients have developed the rare blood disorder thrombocytopenia, with at least several cases resulting in death.
A Food and Drug Administration (FDA) spokesperson told The Epoch Times via email that the agency is investigating and assessing the reported cases.
“At this time, we have not found a causal relationship,” the spokesperson said. “We will update the public as we learn more about these events.”
The blood disorder was listed by the FDA last year as a possible adverse event outcome from getting a COVID-19 vaccine, alongside other serious adverse events like Guillain-Barré syndrome and death.
Several dozen case reports of post-vaccination thrombocytopenia have been submitted to the Vaccine Adverse Event Reporting System (VAERS), a passive reporting system managed by the FDA and the Centers for Disease Control and Prevention. Approximately 44.7 million doses of COVID-19 vaccines have been administered in the United States as of Feb. 10.